Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicine for treating hepatitis B and preparation method thereof

A hepatitis B drug technology, applied in the field of preparation of the drug, can solve the problems of hepatitis B virus not being clear, not obvious effect, and large toxic and side effects, and achieve safe and reliable clinical application, no toxic and side effects, and obvious effect Effect

Inactive Publication Date: 2010-04-28
山西省屯留县科技情报服务中心
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In recent years, the number of patients with hepatitis B disease has increased day by day, especially the infection of hepatitis B virus has become a serious problem affecting social health at present, and China is a high incidence area of ​​hepatitis B disease. The immune response of hepatitis B virus, ten hepatitis B virus is not clear, the liver cells are damaged, and the hepatitis B virus replicates. At present, some western medicine products, such as interferon and acyclovir, have certain anti-hepatitis B virus effects, but due to the large toxic and side effects , on the contrary, it may lead to the deterioration of some liver functions, and the price is expensive, so it is difficult to popularize and apply clinically
In addition, some traditional Chinese medicines have less toxic and side effects, but they cannot effectively resist hepatitis B virus and keep its replication, and cannot induce interferon, so the therapeutic effect is not far from the ideal
The effect of traditional treatment methods is not obvious or can not be cured, and it is accompanied by hair loss. In severe cases, the stomach will gradually become larger. If treatment is delayed, a small number of patients will develop severe hepatitis

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0020] Prepare raw materials according to the following weights:

[0021] 15 grams of astragalus, 15 grams of salvia, 15 grams of silkworm excrement, 10 grams of codonopsis, 10 grams of Guanzhong, 30 grams of coix seed, 30 grams of mushrooms, 6 grams of Bupleurum, 10 grams of fleas, 15 grams of Ligustrum lucidum, Citrus aurantium 10 grams, 10 grams of white peony, 10 grams of Atractylodes macrocephala, 6 grams of licorice, 20 grams of rabbit silk, 10 grams of toosendan.

[0022] Mix the components in the above mass ratio, add 2-4 times the amount of water, and decoct the filtrate with water, generally decocting for 30 minutes is advisable. Use this method to decoct 3 times in water, take the filtrate of the three times, mix them, sterilize, and make oral liquid.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a medicine for treating hepatitis B which is a Chinese herbal medicine medicament prepared from astragalus mongholicus, radix salviae miltiorrhizae, silkworm feculae, codonopsis pilosula, cyrtomium fortunei, coix seed, herba artemisiae scopariae, radix bupleuri, pariphyllin, glossy privet fruit, immature bitter orange, white peony root, white atractylodes rhizome, liquorice, field dodder and szechwan Chinaberry fruit. Clinical test results prove that the medicine of the invention has exact medicine effect and no toxic and side effect and is safe and reliable for clinic application.

Description

technical field [0001] The invention relates to a medicine for treating hepatitis B, in particular to a medicine for treating hepatitis B prepared from Chinese herbal medicines, and also relates to a preparation method of the medicine. Background technique [0002] Hepatitis B, also known as serum hepatitis and viral hepatitis B (referred to as hepatitis B), is an infectious disease caused by hepatitis B virus (HBV). Transmitted through blood and body fluids, with a chronic carrier state. In recent years, the number of patients with hepatitis B disease has increased day by day, especially the infection of hepatitis B virus has become a serious problem affecting social health at present, and China is a high incidence area of ​​hepatitis B disease. The immune response of hepatitis B virus, ten hepatitis B virus is not clear, the liver cells are damaged, and the hepatitis B virus replicates. At present, some western medicine products, such as interferon and acyclovir, have cer...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/8994A61P1/16A61P31/20A61K35/64
Inventor 郝贵成
Owner 山西省屯留县科技情报服务中心
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products